Lynn A. Tetrault is Director of NEOGENOMICS INC. Currently has a direct ownership of 50,062 shares of NEO, which is worth approximately $687,351. The most recent transaction as insider was on Mar 04, 2024, when has been sold 6,112 shares (Common Stock) at a price of $15.97 per share, resulting in proceeds of $97,608. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.1K
0% 3M change
10.88% 12M change
Total Value Held $687,351

LYNN A. TETRAULT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2024
SELL
Open market or private sale
$97,608 $15.97 p/Share
6,112 Reduced 10.88%
50,062 Common Stock
May 22 2023
BUY
Exercise of conversion of derivative security
$17,481 $11.6 p/Share
1,507 Added 2.61%
56,174 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
15,556 Added 22.15%
54,667 Common Stock
May 18 2022
BUY
Exercise of conversion of derivative security
$24,238 $7.27 p/Share
3,334 Added 7.85%
39,111 Common Stock
Oct 11 2021
BUY
Grant, award, or other acquisition
-
838 Added 2.29%
35,777 Common Stock
Jun 11 2021
BUY
Exercise of conversion of derivative security
$12,654 $9.11 p/Share
1,389 Added 3.82%
34,939 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
3,081 Added 8.41%
33,550 Common Stock

Also insider at

RYTM
RHYTHM PHARMACEUTICALS, INC. Healthcare
SLRN
ACELYRIN, Inc.
LAT

Lynn A. Tetrault

Director
Fort Myers, FL

Track Institutional and Insider Activities on NEO

Follow NEOGENOMICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NEO shares.

Notify only if

Insider Trading

Get notified when an Neogenomics Inc insider buys or sells NEO shares.

Notify only if

News

Receive news related to NEOGENOMICS INC

Track Activities on NEO